Login

Join Now

Utah Life Sciences Companies' COVID-19 News

April 16, 2021
PhotoPharmics Innovations Address Global Health Inequalities

PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’ pending Medicare Coverage of Innovative Technology (MCIT) rule and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income. Innovation not only brings improved treatments to address […]

April 16, 2021
SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]

April 16, 2021
Innovative Med Tech Startup Xenter Announces Company Launch

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]

April 16, 2021
Utah’s Recursion Goes Public – Announces Pricing of IPO

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]

April 9, 2021
IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

March 19, 2021
FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]

March 11, 2021
Utah’s Biomerics Announces Expansion of Texas, Costa Rica Operations

Biomerics, headquartered in Salt Lake City, and a leading mid-market medical device contract manufacturer, has announced it is expanding its manufacturing footprint in Athens, TX where Biomerics FMI is a vertically integrated high volume catheter development and manufacturing leader in the attractive PTA, Endourology, and Endoscopy markets. The Texas expansion totals 24,000 sq. ft. including […]

March 1, 2021
IONIQ Sciences Finalist in National ‘Buzz of BIO’ Awards

Utah’s own IONIQ Sciences was named a finalist for the prestigious ‘Buzz of BIO 2021’ award in the ‘Diagnostic and Beyond’ category. Although IONIQ did not win the category, being among the top finalists is a signiicant distinction. Placement was determined by companies receiving the most votes. “We’re on a mission to modernize cancer detection […]

March 1, 2021
Co-Diagnostics, Inc. Partner to Offer At-Home Saliva Collection Kits for CoPrimer™-Based COVID-19 PCR Test Through Walgreens Find Care®

Co-Diagnostics has announced that laboratory partner Clinical Reference Laboratory’s (CRL) FDA-authorized Rapid Response COVID-19 Saliva Test, which uses Co-Diagnostics CoPrimer™ technology, is now available through Walgreens Find Care®, allowing consumers a convenient, non-invasive option for PCR-based COVID-19 testing from their own. Dwight Egan, Co-Diagnostics CEO, stated, “Co-Diagnostics is proud that our technology will be available […]

March 1, 2021
The University of Utah and RenalytixAI Partner to Drive Innovation in Kidney Health

Utah’s RenalytixAI and the University of Utah last week announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease. The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions […]

February 12, 2021
American Society of Nephrology and Renalytix Co-Host Virtual Capital Markets Day for Kidney Health

RenalytixAI co-hosted a Capital Markets Day for Kidney Health with the American Society of Nephrology yesterday, Feb. 11. The virtual event brought together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a […]

February 12, 2021
Attostat is now EVŌQ Nano – Seeks Next Round of Investment Following Antimicrobial Efficacy Studies

Attostat is now EVŌQ Nano! The Utah start-up has a new name, a clean look and a fresh website. Following years of scientific research and development, EVŌQ Nano is ready to share its story of next-generation nanotechnology and raise its next round of investment. “We truly are a thought leader in nanotechnology,” said CEO Scott […]

February 5, 2021
Novel Embolic Device Used for Arterial and Venous Tumor Treatments

Fluidx Medical Technology has announced successful patient use of the GPX Embolic Device to therapeutically devascularize, or block blood supply to, a tumor. The GPX Embolic Device is an innovative embolic designed to combine the benefits of other embolics like coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term […]

January 29, 2021
MAYOR ERIN MENDENHALL’S SALT LAKE CITY 2021 PLAN INCLUDES BIOHIVE

Last week, Salt Lake City (SLC) Mayor Erin Mendenhall gave her second State of the City address – a live broadcast from the City Council Chambers in which she reflected on 2020 and outlined her plan for the City in 2021. The Mayor noted that “we are striving to make our city better through change; […]

January 29, 2021
Spectrum Solutions Collaborates with UCLA on Saliva-Based Next-Gen Sequencing (NGS) Liquid Biopsy Research for the Early Detection of Lung Cancer

Spectrum Solutions, LLC on January 27 announced it is sponsoring research in collaboration with the UCLA School of Dentistry for a study on using saliva in early lung cancer detection and analysis. Spectrum has funded a study that aims to recruit 50 patients with lung cancer and seeks to validate saliva’s tumor-specific ctDNA detection sensitivity […]